Literature DB >> 20490762

Decisive role of lipopolysaccharide in activating nitric oxide and cytokine production by the probiotic Escherichia coli strain Nissle 1917.

Z Zídek1, E Kmonícková, P Kostecká, H Tlaskalová-Hogenová.   

Abstract

Effects of Gram-negative probiotic E. coli strain Nissle 1917 (EcN) on the production of nitric oxide (NO) and cytokines were determined in cultures of resident peritoneal cells of rats. The cells (2 x 10(6)/mL) were cultured for 24 h in the presence of live EcN suspension (EcN-Susp), bacteria-free supernatant of this suspension (Sup-EcN), and LPS of EcN origin (LPS-EcN). The biosynthesis of NO was substantially enhanced using live bacteria counts as low as 10(3)/mL applied in the form of EcN-Susp. The same NO-enhancing effect was produced by the correspondingly diluted Sup-EcN. It was found that Sup-EcN contained relatively high amounts of LPS. Administration of the LPS-EcN mimicked the high NO-augmenting activities of both Sup-EcN and EcN-Susp. However, the activity of LPS-EcN was significantly less pronounced than were the activities of Sup-EcN and EcN-Susp containing identical amounts of LPS. The NO-stimulatory effects of the EcN preparations were completely inhibited by polymyxin B. All LPS-EcN and correspondingly diluted Sup-EcN and EcN-Susp stimulated the secretion of cytokines TNF-alpha, IL-1beta, IL-6, IL-10 and VEGF. Also these effects were abrogated by polymyxin B. In contrast to the effects on NO production, the cytokine-stimulatory effects were significantly less pronounced after the exposure of the cells to Sup-EcN and EcN-Susp than to the identical amounts of LPS-EcN. It may be concluded that the in vitro stimulatory effects of EcN on NO and cytokine production are mediated by LPS. It is suggested that the immunostimulatory activity of LPS is modulated by EcN-derived factor(s), the nature of which remains to be identified.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20490762     DOI: 10.1007/s12223-010-0027-4

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  50 in total

Review 1.  Probiotics as biotherapeutic agents: present knowledge and future prospects.

Authors:  A Mercenier; S Pavan; B Pot
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

2.  Generation of NO by probiotic bacteria in the gastrointestinal tract.

Authors:  Tanja Sobko; Liyue Huang; Tore Midtvedt; Elisabeth Norin; Lars E Gustafsson; Mikael Norman; Emmelie A Jansson; Jon O Lundberg
Journal:  Free Radic Biol Med       Date:  2006-07-04       Impact factor: 7.376

3.  Potentiation of lipopolysaccharide-induced IL-6 release by uridine triphosphate in macrophages: cross-interaction with cyclooxygenase-2-dependent prostaglandin E(2) production.

Authors:  B C Chen; W W Lin
Journal:  J Biomed Sci       Date:  1999 Nov-Dec       Impact factor: 8.410

4.  p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.

Authors:  C C Chen; J K Wang
Journal:  Mol Pharmacol       Date:  1999-03       Impact factor: 4.436

5.  Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

Authors:  Andreas Sturm; Klaus Rilling; Daniel C Baumgart; Konstantinos Gargas; Tay Abou-Ghazalé; Bärbel Raupach; Jana Eckert; Ralf R Schumann; Corinne Enders; Ulrich Sonnenborn; Bertram Wiedenmann; Axel U Dignass
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

Authors:  H A Malchow
Journal:  J Clin Gastroenterol       Date:  1997-12       Impact factor: 3.062

7.  Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.

Authors:  Lubomir Grozdanov; Carsten Raasch; Jürgen Schulze; Ulrich Sonnenborn; Gerhard Gottschalk; Jörg Hacker; Ulrich Dobrindt
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

8.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

9.  The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.

Authors:  Artur Altenhoefer; Sibylle Oswald; Ulrich Sonnenborn; Corinne Enders; Juergen Schulze; Joerg Hacker; Tobias A Oelschlaeger
Journal:  FEMS Immunol Med Microbiol       Date:  2004-04-09

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota.

Authors:  Alexander V Oleskin; Boris A Shenderov
Journal:  Microb Ecol Health Dis       Date:  2016-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.